PMGC (NASDAQ:ELAB) Stock Price Up 5.7% – Should You Buy?

PMGC Holdings Inc. (NASDAQ:ELAB) shares traded up 5.7% during mid-day trading on Friday . The company traded as high as $1.56 and last traded at $1.12. 35,400,837 shares were traded during mid-day trading, an increase of 915% from the average daily volume of 3,488,120 shares. The stock had previously closed at $1.06.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research report on Friday, June 26th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, PMGC presently has an average rating of “Sell”.

PMGC Trading Up 5.7%

The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.43 and a current ratio of 1.45. The stock has a market capitalization of $1.30 million, a PE ratio of -0.01 and a beta of -0.23. The stock has a 50-day moving average price of $1.59 and a two-hundred day moving average price of $9.25.

PMGC (NASDAQ:ELAB) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($11.22) earnings per share (EPS) for the quarter. The company had revenue of $0.68 million during the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.